Profilo
Keld Søndergaard worked as a Director at Xintela AB in 2017 and as the Chief Financial Officer at AFYX Therapeutics AS.
Precedenti posizioni note di Keld Søndergaard
| Società | Posizione | Fine |
|---|---|---|
| XINTELA AB | Direttore/Membro del Consiglio | 17/10/2017 |
AFYX Therapeutics AS
 AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | Direttore Finanziario/CFO | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| XINTELA AB | Health Technology |
| Aziende private | 1 |
|---|---|
AFYX Therapeutics AS
AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | Commercial Services |
- Borsa valori
- Insiders
- Keld Søndergaard
